Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by INVSTIGAT0Ron May 09, 2019 9:44am
100 Views
Post# 29728338

Been doing some research

Been doing some researchI thought I'd share with the board:

Abbvie Inc (ABBV) is a biotech company I recently came across that has an FDA approved synthetic THC drug. Market cap of ~114 billion and revenues of ~33 billion. It also has a pretty high dividend over 5%. It looks like it's been consolidating around $77 after a run over $123+. Looks like a pretty solid addition to a weed portfolio. I'm looking to add myself once the downtrend appears to be over. Hoping for $60s. 


Bullboard Posts